|
|
|
|
More About |
|
New Site/Investigator Development
|
|
|
|
|
|
|
|
Site Identification and Selection |
|
TrialAdvance is a valuable resource for study sponsors in identifying potential investigative sites and thoroughly training new sites to ensure optimum effectiveness. We have significant experience in site feasibility modeling. Our unique research methodology uncovers those site characteristics necessary for high performance in conducting a specific protocol. We can also identify potential new investigators who may have access to the needed patient population and then train them in all aspects of clinical research, including site operations, study start-up, patient-recruitment strategies, and sponsor/site relationship building.
|
|
TrialAdvance has trained and successfully developed a range of investigative sites — from large academic institutions and medical centers to for-profit investigative research centers to individual physician practice groups and sole practitioners.
|
|
|
|
Multicultural Site Recruitment |
|
Racial- and ethnic-segmentation strategies demand a departure from business as usual in the development of clinical trials, especially in the areas of patient recruitment, enrollment, and retention. It is necessary to adopt a new mindset and new skills to adequately address patient skepticism and deeply rooted mistrust about the relevance and accuracy of healthcare information, medical institutions, and the industry itself. Proactively researching, initiating contact with, and establishing relationships with investigators who belong to those diverse racial and ethnic groups is imperative.
|
|
TrialAdvance has years of experience working with these highly sought-after investigators and potential investigators, helping them maximize their study performance. Utilizing our own resources, along with those of our strategic partner (which has relationships with many professional groups to which these investigators belong), TrialAdvance can help study teams build better site/sponsor relationships and improve site loyalty for future studies.
|
|
|
|
Site Operations Consulting
|
|
TrialAdvance CEO Kathleen Drennan cofounded and built one of the largest and most successful independent investigative site of its time. She oversaw a massive operation that conducted over 100 drug and nutrition studies annually — and she managed a staff of 60 investigators and clinical research coordinators. With her unique experience and insight, Kathleen Drennan and the TrialAdvance team can quickly evaluate the quality of site operations and the likelihood of the site being a high performer with respect to a specific study protocol.
|
|
We believe that the key to clinical trial success begins and ends with the investigative sites. TrialAdvance has been retained by both study sponsors and individual investigators and sites that want to attract more clinical research funding. As part of its consulting process, TrialAdvance first conducts a thorough evaluation of site capabilities, operational efficiency, and past success with conducting clinical trials. We then identify where gaps exist in infrastructure, personnel, knowledge, and training and then propose practical strategies and tactics to address these needs.
|
